The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: Results from the NOPHO ALL-2000 trial

Leukemia

Volumn 25, Issue 4, 2011, Pages 622-628

  Zachariadis, V ^a   Gauffin, F ^a   Kuchinskaya, E ^a   Heyman, M ^a   Schoumans, J ^a,g   Blennow, E ^a   Gustafsson, B ^a   Barbany, G ^a   Golovleva, I ^b   Ehrencrona, H ^c   Cavelier, L ^c   Palmqvist, L ^d   Lonnerholm G ^e   Nordenskjold M ^a   Johansson, B ^f   Forestier, E ^b   Nordgren, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY CHILDREN S HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

acute lymphoblastic leukemia; dic(9; 20); FISH

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 11; CHROMOSOME 13; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 21; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME G BAND; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 12; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); DICENTRIC CHROMOSOME; DIPLOIDY; EVENT FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENDER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRE B LYMPHOCYTE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SCANDINAVIA;

EID: 79954444344     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.318     Document Type: Article

References (24)

1. Rieder H, Schnittger S, Bodenstein H, Schwonzen M, Wormann B, Berkovic D et al. dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer 1995; 13: 54-61.
2. Slater R, Smit E, Kroes W, Bellomo MJ, Muhlematter D, Harbott J et al. A non-random chromosome abnormality found in precursor-B lineage acute lymphoblastic leukaemia: dic(9;20)(p13;q11). Leukemia 1995; 9: 1613-1619.
3. Heerema NA, Maben KD, Bernstein J, Breitfeld PP, Neiman RS, Vance GH. Dicentric (9;20)(p11;q11) identified by fluorescence in situ hybridization in four pediatric acute lymphoblastic leukemia patients. Cancer Genet Cytogenet 1996; 92: 111-115. (Pubitemid 26427672)
4. Clark R, Byatt SA, Bennett CF, BramaM,Martineau M, Moorman AV et al. Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Leukemia 2000; 14: 241-246. (Pubitemid 30095378)
5. Forestier E, Gauffin F, Andersen MK, Autio K, Borgstrom G, Golovleva I et al. Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)- positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature. Genes Chromosomes Cancer 2008; 47: 149-158.
6. Pichler H, Moricke A, Mann G, Teigler-Schlegel A, Niggli F, Nebral K et al. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Munster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. Br J Haematol 2010; 149: 93-100.
7. Moorman AV, Ensor HM, Richards SM, Chilton L, Schwab C, Kinsey SE et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol 2010; 11: 429-438.
8. Heerema NA, Sather HN, Sensel MG, Liu-Mares W, Lange BJ, Bostrom BC et al. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 1999; 94: 1537-1544. (Pubitemid 29411302)
9. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations and gene fusions in cancer. http://cgap.nci.nih.gov/Chromosomes/ Mitelman. Accessed May 28, 2010.
10. Song X, Gong S, Yang J, Wang J. Clinical and molecular cytogenetic characteristics of dic(9;20) in adult acute lymphoblastic leukemia: a case report of three patients. Ann Hematol 2007; 86: 347-351. (Pubitemid 46477298)
11. An Q, Wright SL, Konn ZJ, Matheson E, Minto L, Moorman AV et al. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer. Proc Natl Acad Sci USA 2008; 105: 17050-17054.
12. An Q, Wright SL, Moorman AV, Parker H, Griffiths M, Ross FM et al. Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11 21. Haematologica 2009; 94: 1164-1169.
13. Jarosova M, Holzerova M, Mihal V, Lakoma I, Divoky V, Blazek B et al. Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21. cases. Cancer Genet Cytogenet 2003; 145: 161-168. (Pubitemid 36993748)
14. Rabin KR, Man TK, Yu A, Folsom MR, Zhao YJ, Rao PH et al. Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008; 51: 171-177. (Pubitemid 351874408)
15. Schoumans J, Johansson B, Corcoran M, Kuchinskaya E, Golovleva I, Grander D et al. Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11 2. Br J Haematol 2006; 135: 492-499. (Pubitemid 44583413)
16. Strefford JC, Worley H, Barber K, Wright S, Stewart AR, Robinson HM et al. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene 2007; 26: 4306-4318. (Pubitemid 46975791)
17. Schmiegelow K, Forestier E, Hellebostad M, Heyman M, Kristinsson J, Soderhall S et al. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 2010; 24: 345-354.
18. Kuchinskaya E, Heyman M, Nordgren A, Söderhäll S, Forestier E, Wehner P et al. Interphase FISH deletion analysis of the 9p21 region and prognosis in childhood ALL: results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol. Br J Haematol (in press).
19. van der Linden MH, Valsecchi MG, De Lorenzo P, Moricke A, Janka G, Leblanc TM et al. Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol. Blood 2009; 114: 3764-3768.
20. Wetzler M, Dodge RK, Mrozek K, Stewart CC, Carroll AJ, Tantravahi R et al. Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B. Br J Haematol 2004; 124: 275-288. (Pubitemid 38167977)
21. Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000; 14: 2267-2275. (Pubitemid 32042267)
22. Moricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010; 24: 265-284.
23. Lönnerholm G, Nordgren A, Frost BM, Jonsson OG, Kanerva J, Nygaard R et al. Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids. Leukemia 2009; 23: 209-212.
24. Mitchell C, Payne J, Wade R, Vora A, Kinsey S, Richards S et al. The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99. Br J Haematol 2009; 146: 424-436.